The Chase Group is proud to partner with Eisai and support their human health care mission by securing a strong and agile leader for their Global Oncology Business Unit. The new Senior Medical Director is driving the medical affairs portfolio and team for the Women’s Cancer Care, Oncology Business Unit. Drawn to Eisai’s patient-focused business mindset, this new medical lead has hit the ground running, contributing to finding innovative solutions in disease prevention, treatment, and care for the health and wellbeing of people worldwide. To learn more about how The Chase Group can help you secure high caliber executive talent, please contact Moira Newbanks at moira@chasegroup.com for more information.
Partnership with The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit
The Chase Group is proud to partner with Eisai and support their human health care mission by securing a strong and agile leader for their Global Oncology Business Unit. The new Senior Medical Director is driving the medical affairs portfolio and team for the Women’s Cancer Care, Oncology Business Unit. Drawn to Eisai’s patient-focused business mindset, this new medical lead has hit the ground running, contributing to finding innovative solutions in disease prevention, treatment, and care for the health and wellbeing of people worldwide. To learn more about how The Chase Group can help you secure high caliber executive talent, please contact Moira Newbanks at moira@chasegroup.com for more information.- Categories: Life Sciences, Pharmaceutical
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…
Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership with The Chase Group
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained…
Leadership Team Grows at Biologics Consulting Through Partnership with The Chase Group
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,…-
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. -
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development… 
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…